ARCHIVES

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

This article is from The Cancer Letter archive.

Vol. 12 No. 14 | April 4, 1986

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

Lippman Named UCSD Cancer Center Director

May 4, 2012

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995